Harshal Bhagwatwar

Title: Harshal Bhagwatwar: Innovator in Pharmaceutical Formulations

Introduction

Harshal Bhagwatwar is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid formulations for cancer treatment. With a total of five patents to his name, Bhagwatwar's work is recognized for its innovative approach to enhancing the efficacy of pharmaceutical compounds.

Latest Patents

One of Harshal Bhagwatwar's latest patents focuses on stable liquid formulations of cyclophosphamide. This invention relates to pharmaceutical formulations that comprise cyclophosphamide and at least one pharmaceutically acceptable excipient, with a moisture content of less than about 2.0% by weight. The process involves reducing the moisture content from cyclophosphamide or its liquid compositions. Furthermore, the stable liquid formulations are designed for parenteral administration, either as ready-to-use or ready-to-dilute options for treating various cancer disorders.

Career Highlights

Throughout his career, Harshal Bhagwatwar has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Dr. Reddy's Laboratories and Avyxa Holdings, LLC. His experience in these organizations has contributed to his expertise in pharmaceutical formulations and innovation.

Collaborations

Harshal Bhagwatwar has collaborated with several professionals in his field, including Riyaz Ahmed Shaik and Ananya Saha. These collaborations have likely enriched his work and contributed to the development of his innovative patents.

Conclusion

Harshal Bhagwatwar stands out as a significant figure in the pharmaceutical industry, particularly for his advancements in stable liquid formulations for cancer treatment. His contributions through patents and collaborations reflect his commitment to innovation in healthcare.